FP
Fennec Pharmaceuticals Inc
🇩🇪XSTU.RV41GermanyHealthcare
€9.00EURdown -0.30 (-3.23%)OpenEnd of day6:29 PM
Price€9.00-0.30 (-3.23%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- CA31447P1009
- CUSIP
- Not reported
Company
- Employees
- 35
- Headquarters
- Research Triangle Park, United States
- Website
- https://www.fennecpharma.com
- CEO
- Mr. Jeffrey S. Hackman
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $59.22M+77.83%up year on year
- Net income
- -$3.25M+72.99%up year on year
- Gross margin
- 93.73%+4.27%up year on year
- Free cash flow
- -$2.04M+82.54%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.